In addition, bromocriptine, a DA agonist, has been shown to inhibit the proliferation of murine ACTH-secreting pituitary adenoma cells [56] and cabergoline treatment in primary cultures of canine ACTH-secreting adenomas moderately expressing D2R-reduced ACTH secretion [57]. This evidence concerns the gene POMC and adenoma.